Earlier this year Plumb Pharmaceuticals, Inc. secured investment from the Winnow Fund, a Madison-based venture capital fund investing in pre-seed Wisconsin-headquartered startups with a particular focus on opportunities spinning out of the state’s public and private colleges and universities.
Plumb was founded in 2016 by Drs. Tim Heath, Ph.D., and Lisa Krugner-Higby, DVM, Ph.D., professors at the University of Wisconsin-Madison, and is dedicated to solving problems of medication compliance with extended-release formulations of FDA-approved drugs. Both individuals are serving in executive roles with the company.
Plumb’s first product in development combines their Advanced Quantload (AQL™) lipid-based extended-release drug technology with naltrexone, a drug commonly used to treat alcohol and opioid addiction.